Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.34 SEK | -4.63% | -3.60% | -66.46% |
05-15 | Transcript : Scandion Oncology A/S - Special Call | |
03-21 | Scandion Oncology Reports Updated Phase II Corist Data, Including Topline Overall Survival | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.46% | 5.34M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.77% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- SCOL Stock
- News Scandion Oncology A/S
- Transcript : Scandion Oncology A/S, Q4 2022 Earnings Call, Feb 22, 2023